Monte Rosa Therapeutics (GLUE) PT Raised to $22 at Jefferies
Tweet Send to a Friend
Jefferies analyst Kelly Shi raised the price target on Monte Rosa Therapeutics (NASDAQ: GLUE) to $22.00 (from $18.00) while ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
